YONKERS, N.Y.--(BUSINESS WIRE)--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a bio-pharmaceutical company, announced today that new information on AVR118 has been accepted for publication in the 2007 Proceedings of the American Society of Clinical Oncology (ASCO) Abstract publication. This publication will be distributed to the nearly 25,000 oncology practioners who will be attending this year’s meeting in Chicago on June 1-5.
